140 related articles for article (PubMed ID: 26270118)
1. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
2. The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.
Tian S; Zhang L; Yang T; Wei X; Zhang L; Yu Y; Li Y; Cao D; Yang X
Mediators Inflamm; 2018; 2018():9127146. PubMed ID: 30147445
[TBL] [Abstract][Full Text] [Related]
3. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
[TBL] [Abstract][Full Text] [Related]
4. Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects.
Wan GX; Cao YW; Li WQ; Li YC; Zhang WJ; Li F
Asian Pac J Cancer Prev; 2014; 15(19):8279-85. PubMed ID: 25339018
[TBL] [Abstract][Full Text] [Related]
5. TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants.
Paradowska E; Jabłońska A; Studzińska M; Skowrońska K; Suski P; Wiśniewska-Ligier M; Woźniakowska-Gęsicka T; Nowakowska D; Gaj Z; Wilczyński J; Leśnikowski ZJ
PLoS One; 2016; 11(4):e0154100. PubMed ID: 27105145
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.
Moura EL; Santos IFD; Freitas PP; Silva DMD; Santos ACMD; Lira Neto AB; Silva ACPE; Barbosa NR; Nascimento CA; Balliano TL; Fraga CAC; Farias KF; Figueiredo EVMS
Immunobiology; 2022 Mar; 227(2):152187. PubMed ID: 35158151
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Biol Rep; 2012 Aug; 39(8):8425-30. PubMed ID: 22714906
[TBL] [Abstract][Full Text] [Related]
8. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility.
Chen X; Wang S; Liu L; Chen Z; Qiang F; Kan Y; Shen Y; Wu J; Shen H; Hu Z
DNA Cell Biol; 2012 May; 31(5):766-71. PubMed ID: 22059466
[TBL] [Abstract][Full Text] [Related]
9. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
Jin Y; Qiu S; Shao N; Zheng J
Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
[TBL] [Abstract][Full Text] [Related]
10. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
12. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
13. Association of TLR4 and TLR9 gene polymorphisms with cervical HR-HPV infection status in Chinese Han population.
Zhang C; Yang Z; Luo P; Li T; Wang S; Sun F; Gong P; Mei B
BMC Infect Dis; 2023 Mar; 23(1):152. PubMed ID: 36915050
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis.
Li J; Tao JH; Gao W; Fan Y; Lu MM; Li R; Li XP; Ye DQ
Mod Rheumatol; 2012 Aug; 22(4):550-6. PubMed ID: 22228476
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies.
Lee YH; Song GG
Lupus; 2023 Jul; 32(8):964-973. PubMed ID: 37265090
[TBL] [Abstract][Full Text] [Related]
16. TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.
Wang D; Zhang C; Zhou Z; Pei F
Rheumatol Int; 2016 Apr; 36(4):585-95. PubMed ID: 26643792
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract][Full Text] [Related]
18. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients.
Kim TH; Jeong KH; Kim SK; Lee SH; Ihm CG; Lee TW; Moon JY; Yoon YC; Chung JH; Park SJ; Kang SW; Kim YH
Int J Immunogenet; 2013 Dec; 40(6):502-8. PubMed ID: 23758740
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
Lai ZZ; Ni-Zhang ; Pan XL; Song L
J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
